Abstract |
Hepatocellular carcinoma (HCC) is the fifth most malignant tumor worldwide and is known to be resistant to conventional chemotherapy. New therapeutic strategies are urgently needed for treating HCC. Lup-20(29)-en-3H-ol ( Lupeol), a novel dietary triterpene, is found in fruits, vegetables, and medicinal plants and possesses multiple bio-activities with very low toxicity. In the current study, we investigated its growth-inhibitory effects in HCC cell lines SMMC7721 and HepG2. In the in vitro studies, lupeol treatment alone caused decrease of cell viability in two HCC cell lines in a dose-dependent manner. It also induced apoptosis and caused cell accumulation in S phase. Further analysis revealed the induction of active caspase-3 and poly(ADP-ribose)polymerase (PARP) cleavage by lupeol treatment. In the in vivo studies, nude mice implanted with SMMC7721 cells subcutaneously were treated with lupeol three times a week and tumor development was significantly inhibited. We further investigated the combination anti- tumor effect of lupeol and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in HCC, considering TRAIL treatment alone could not achieve high level of anti- tumor effect. The results demonstrated that lupeol could exert a combinational effect with TRAIL, resulting in chemosensitization of HCC. Our results suggested that lupeol alone or as an adjuvant to therapeutic agents could be developed as a potential agent for treating HCC.
|
Authors | Yan He, Fen Liu, Lurong Zhang, Yan Wu, Bo Hu, Yinsheng Zhang, Yunsen Li, Haiyan Liu |
Journal | Biological & pharmaceutical bulletin
(Biol Pharm Bull)
Vol. 34
Issue 4
Pg. 517-22
( 2011)
ISSN: 1347-5215 [Electronic] Japan |
PMID | 21467639
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Pentacyclic Triterpenes
- Plant Extracts
- TNF-Related Apoptosis-Inducing Ligand
- Poly(ADP-ribose) Polymerases
- Caspase 3
- lupeol
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Carcinoma, Hepatocellular
(metabolism, prevention & control)
- Caspase 3
(metabolism)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Chemotherapy, Adjuvant
- Dose-Response Relationship, Drug
- Hep G2 Cells
- Humans
- Liver Neoplasms
(metabolism, prevention & control)
- Mice
- Mice, Nude
- Pentacyclic Triterpenes
(pharmacology, therapeutic use)
- Phytotherapy
- Plant Extracts
(pharmacology, therapeutic use)
- Poly(ADP-ribose) Polymerases
(metabolism)
- TNF-Related Apoptosis-Inducing Ligand
(pharmacology, therapeutic use)
|